DigitCells launches TWO-D at AUA
CHICAGO, May 1, 2024 /PRNewswire-PRWeb/ -- DigitCells, a leading innovator in complete digital pathology solutions and a subsidiary company of GoPath Diagnostics, is excited to announce the launch of its groundbreaking Tissue Workflow Optimization for Digital (TWOD) system for prostate at the upcoming 2024 American Urological Association (AUA) Annual Meeting in San Antonio, Texas.
The TWOD system ushers in a new era of high-efficiency and cost-effectiveness in pathology
The TWOD system streamlines biopsy tissue workflows, significantly enhancing efficiency to meet the demands of today's pathology environment. It encompasses the entire process, from initial acquisition in the clinician's office, through comprehensive tracking within the histology lab, to final digital sign-out by pathologists. TWOD improves workflow efficiency providing a greater benefit of digital pathology adoption. This efficiency gain is achieved through a significant reduction in traditional consumable usage by up to 33%, leading to a 40% improvement in overall laboratory productivity. The benefits of TWOD include- preserved specimen integrity, substantial financial savings, and heightened diagnostic efficacy. These combined advantages make digital pathology a more compelling choice for the modern healthcare system.
Innovation at its Core: Optimizing the Entire Tissue Workflow for Better Patient Care
TWOD's most innovative features are the combination of its proprietary barcoded tissue cassettes, the 12-core biopsy station for urologists, its transportation method and live core measurement technologies. The patent- pending cassette design houses each core of biopsy tissue in a stable environment, while preserving it in formalin during transportation, ensuring the integrity of tissues without fragmentation upon receiving. With the tissues housed in-situ cassettes, they are ready for tissue processing after a live digital measurement, eliminating any need to “pick” the tissue from formalin jars or any other type of device.
Our unique barcode tracking, color coded system allows the specimen to be tracked throughout the entire process, starting from the clinician’s side and throughout the histology lab, thereby ensuring complete tissue identity retention. This process is centrally managed by TWOD’s proprietary LIS system that integrates our Image Management System (IMS), AI and pathology signing- out functions by pathologists.
TWOD is a Leap Towards a Future Where Efficient Digital Diagnosis is More Accessible
"We are thrilled to unveil the TWOD system at this year's AUA Annual Meeting," said Dr. Jim Lu, CEO and Medical Director of GoPath Diagnostics, the parent company of DigitCells Inc. "The current histology workflow, which has been used for nearly a century, is not optimized for today's digital pathology setting. The TWOD system bridges the gap between histopathology and digital pathology, reducing cost and improving workflow efficiency. While we are focused on launching TWOD for prostate, our plans is to expand its capability into GI, breast and dermatology. We are proud to be setting a new benchmark in the industry with our TWOD system to help our colleagues embrace digital pathology in their practice".
Experience TWOD at AUA Booth 823
Visit the TWOD pop-up at AUA at booth 823 to see the system in action. Live demonstrations will be conducted on Friday, May 3rd, and Saturday, May 4th, from 9 AM to 4 PM. Attendees will have the opportunity to engage directly with the TWOD system and gain firsthand experience of its practical benefits and capabilities.
About DigitCells
DigitCells, a leading technology company specializing in comprehensive digital pathology solutions, empowers pathologists worldwide to enhance efficiency, accuracy, and collaboration. Our offerings encompass quality hardware, intuitive software, and secure cloud-based services designed to support you throughout your entire digital journey. Partner with DigitCells and experience high-fidelity image capture, powerful digital capabilities, streamlined laboratory operation, enhanced collaboration and knowledge sharing with expert support and guidance every step of the way. Together, we can unlock the full potential of pathology and create a more efficient, collaborative, and accurate future for patients everywhere.
About GoPath
GoPath Diagnostics specializes in molecular, genetics, anatomic pathology, hematopathology, cytology, and digital pathology services. With advanced technologies and an experienced team of laboratory professionals, GoPath Diagnostics provides accurate, reliable, and timely test results to enable clinical healthcare providers to make informed treatment decisions and to empower pathologists by enhancing their molecular and digital capabilities.
Media Contact
Edgar Castellanos, DigitCells, 1 2245156999, [email protected], https://digitcells.com/
SOURCE DigitCells
Share this article